RxVantage
Latest round
- Series B
Last raised
- Jan 2020
Total raised
- $2.5M
Investors
- 3
About RxVantage
RxVantage, Inc.Founded in 2008, RxVantage, Inc. is headquartered in El Segundo, US. The company provides a platform that facilitates connections between healthcare providers and life science companies. The founders, Greg Gilman, James Dwyer, and Jeremy Gilman, have previously established successful ventures.00 mn.RxVantage offers a robust platform designed to facilitate connections between healthcare providers and life science companies, streamlining the educational exchange process. Their core product is an easy-to-use application that enables medical practices to access educational resources, engage with life science representatives, and manage scheduling for meetings efficiently. This solution addresses key challenges faced by healthcare providers, including the need for timely updates on medications, treatment protocols, and patient assistance programs. RxVantage serves a diverse clientele, including over 16,000 medical practices and 100,000 life science experts, primarily within the United States and select international markets.RxVantage generates revenue through a subscription model that connects medical practices with life science representatives and educational resources. Clients pay for access to the platform's features, which include meeting scheduling, instant communication with representatives, and access to a resource library for patient assistance programs. Revenue is derived primarily from healthcare practices subscribing to the service on an annual or monthly basis, establishing a steady income stream. The business model also includes partnerships with life science companies, enhancing the value proposition for both providers and representatives. The company aims to expand into new markets, particularly targeting Europe and Asia by 2025., although financial terms were not disclosed.
Who invested in RxVantage
3 investors across 3 rounds
See all investors in RxVantage
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about RxVantage
Who invested in RxVantage?
RxVantage has 3 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has RxVantage raised?
RxVantage has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did RxVantage last raise money?
RxVantage's most recent round on record is a Series B, in Jan 2020.
What does RxVantage do?
RxVantage is a healthcare it company.
Where is RxVantage headquartered?
RxVantage is headquartered in El Segundo, US.
Which VCs invest in companies like RxVantage?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare it companies at RxVantage's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series B
Raising like RxVantage? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.